HomeGH • NASDAQ
add
Guardant Health Inc
Previous close
$40.46
Day range
$40.13 - $41.06
Year range
$20.14 - $52.92
Market cap
5.04B USD
Avg Volume
2.49M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 203.47M | 20.76% |
Operating expense | 239.30M | 18.02% |
Net income | -95.16M | 17.24% |
Net profit margin | -46.77 | 31.46% |
Earnings per share | -0.49 | -6.52% |
EBITDA | -100.32M | -12.90% |
Effective tax rate | -0.31% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 698.57M | -32.11% |
Total assets | 1.34B | -21.14% |
Total liabilities | 1.60B | -2.52% |
Total equity | -250.79M | — |
Shares outstanding | 123.89M | — |
Price to book | -19.93 | — |
Return on assets | -19.53% | — |
Return on capital | -24.54% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -95.16M | 17.24% |
Cash from operations | -62.69M | -107.00% |
Cash from investing | 302.86M | 979.11% |
Cash from financing | -66.85M | -6,124.39% |
Net change in cash | 174.10M | 4,029.98% |
Free cash flow | -39.66M | 66.61% |
About
Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers. Wikipedia
Founded
2012
Headquarters
Website
Employees
2,010
